Market Tracker

04/17 6:02pm ET

Echo Therapeutics Inc (NASDAQ:ECTE)

1.65
Delayed Data
As of Apr 17
 -0.17 / -9.34%
Today’s Change
0.39
Today|||52-Week Range
3.47
+22.22%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close1.82
Today’s open1.74
Day’s range1.61 - 1.83
Volume148,258
Average volume (3 months)66,660
Market cap$18.4M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc-0.02-2.26%
KBIOKaloBios Pharmaceuti...-0.01-2.22%
RTGNRuthigen Inc-0.14-3.74%
CDXICardax Inc0.000.00%
Data as of 4:00pm ET, 04/17/2015

Financials

Last reporting dateApril 15, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts